Back
Jasper Therapeutics Vs. Theriva Biologics Industry Stock Comparison
Sell
33
JSPR
Jasper Therapeutics
Last Price:
20.68
Seasonality Move:
102.65%
Sell
36
TOVX
Theriva Biologics
Last Price:
1.16
Seasonality Move:
6.22%
Sell
33
Jasper Therapeutics (JSPR)
is a Sell
Is Jasper Therapeutics a Buy, Sell or Hold?
- The current Jasper Therapeutics [JSPR] share price is $20.47. The Score for JSPR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- JSPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Theriva Biologics (TOVX)
is a Sell
Is Theriva Biologics a Buy, Sell or Hold?
- The current Theriva Biologics [TOVX] share price is $1.19. The Score for TOVX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- TOVX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JSPR Stock Price Chart
What is Jasper Therapeutics's stock price today?
-
The Jasper Therapeutics share price today is $20.47
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JSPR is experiencing selling pressure, which indicates risk of future bearish movement.
TOVX Stock Price Chart
What is Theriva Biologics's stock price today?
-
The Theriva Biologics share price today is $1.19
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TOVX is experiencing buying pressure, which is a positive indicator for future bullish movement.
JSPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 41.66 | Sell |
| Chaikin Money Flow: | -121093 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.2 - 23.64) | Sell |
| Bollinger Bands (100): | (17.65 - 22.55) | Buy |
TOVX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 37.98 | Sell |
| Chaikin Money Flow: | 16155 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.15 - 1.63) | Sell |
| Bollinger Bands (100): | (1.14 - 4.58) | Sell |
JSPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.3 | Sell |
| 20-day SMA: | 22.09 | Sell |
| 50-day SMA: | 20.77 | Sell |
| 200-day SMA: | 22.05 | Sell |
| 8-day EMA: | 22.05 | Sell |
| 20-day EMA: | 22.16 | Sell |
| 50-day EMA: | 21.47 | Sell |
| 200-day EMA: | 20.03 | Buy |
TOVX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.27 | Sell |
| 20-day SMA: | 1.29 | Sell |
| 50-day SMA: | 1.49 | Sell |
| 200-day SMA: | 5.95 | Sell |
| 8-day EMA: | 1.25 | Sell |
| 20-day EMA: | 1.34 | Sell |
| 50-day EMA: | 1.78 | Sell |
| 200-day EMA: | 5.52 | Sell |
Jasper Therapeutics Earnings Growth & JSPR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.40 per share, and a decrease next year of $0.14 per share.
Theriva Biologics Earnings Growth & TOVX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.00 per share, and an increase next year of $22.60 per share.
Jasper Therapeutics Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Theriva Biologics Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||